High-dose rate interstitial brachytherapy for mobile tongue cancer: Part 2. Phase III trial of HDR versus LDR interstitial brachytherapy for T1-T2N0 carcinoma of the mobile tongue. [electronic resource]
- Gan to kagaku ryoho. Cancer & chemotherapy May 2000
- 291-5 p. digital